My CPNP

My CPNP provides quick access to the most important features on cpnp.org.

You will see your important notices, and you will have direct access to your exams and other action items.

Log in now to see your personalized page.

User login

Industry News

Goff DC, Midha KK, Sarid-Segal O, Hubbard JW, Amico E. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology (Berl). 1995;117(4):417-23.
Following a 2-week placebo lead-in, schizophrenic patients were randomly assigned to fluoxetine 20 mg/day or placebo added to depot neuroleptic for a 6-week, double blind trial. All patients had received a stable dose of depot neuroleptic for at least 6 months and did not meet criteria for depression. Serum samples were obtained at baseline and at weeks 4 and 6. Scores on the negative symptom subscale of the Brief Psychiatric Rating Scale (BPRS) were significantly lower at week 6, controlling for baseline...
BACKGROUND: An association found between akathisia and iron deficiency led to the suggestion that iron supplementation might be a useful therapeutic intervention for patients with akathisia. There is, however, a body of literature on the abnormal deposition of iron in the brain in several degenerative diseases like Hallervorden-Spatz syndrome, Parkinson's disease, and Alzheimer's disease. Given the ability of neuroleptics to chelate iron and promote its deposition in the brain, we questioned...

CPNP News

College of Psychiatric and Neurologic Pharmacists Releases 2013 Residency Director Survey Results

The College of Psychiatric and Neurologic Pharmacists has released the 2013 Residency Program Director Survey results. Every year, the Resident and New Practitioner Committee asks all Residency Directors with a residency program listed on cpnp.org to complete a brief survey. The purpose of this survey is to gather information which will assist the committee and CPNP in:

College of Psychiatric and Neurologic Pharmacists Announces Election of 2014-2016 Officers

The College of Psychiatric and Neurologic Pharmacists (CPNP) membership has elected three officers to serve on the 2014-2016 Board of Directors. Assuming their offices effective July 1, 2014, will be Drs. Raymond Love, Jennifer Zacher, and Jonathan Lacro. Dr. Love is currently serving the first year of a two-year term as Member at Large to the Board. With his selection as President-Elect, a vacancy on the board will occur on July 1, 2014. CPNP bylaws require that President-Elect Steve Burghart name an individual to complete this 1-year term. Dr. Megan Ehret has been selected and endorsed by the CPNP Board as the individual to complete this term.

College of Psychiatric and Neurologic Pharmacists Announces Slate for 2014-2016 Board Officer Election

The College of Psychiatric and Neurologic Pharmacists (CPNP) Nominations Committee is pleased to announce the consideration of over 60 individuals for 3 positions on the 2014-2016 CPNP Board of Directors. Now narrowed to a slate of 6 candidates, CPNP active members will have the opportunity to select 1 individual to serve in each position. Elections will take place online at cpnp.org from October 21-November 11, 2013. A link to the voting center will be sent via email to all active members on October 21.

The College of Psychiatric and Neurologic Pharmacists (CPNP) announces the recipient of the 2014 Judith J. Saklad Award

The College of Psychiatric and Neurologic Pharmacists (CPNP) is pleased to announce the recipient of the 2014 Judith J. Saklad Award, Cynthia Kirkwood, PharmD, BCPP. Dr. Kirkwood is Professor and Vice Chair for Education for the Department of Pharmacotherapy & Outcomes Science at Virginia Commonwealth University in Richmond, Virginia.

CPNP Commentary Published Advocating for Psychiatric Pharmacist Integration Into the Medical Home

A commentary recently published in the journal Primary Care Companion for CNS Disorders entitled “Psychiatric Pharmacist Integration Into the Medical Home” details the fact that persons with chronic medical illnesses often have co-occurring behavioral health illnesses that require diagnosis and treatment. The publication of this commentary is the culmination of a more than two-year long effort by CPNP members to document our role in the patient care process as psychiatric pharmacists.

If you have any questions, please contact us.